iVector, a core facility for bioproduction of viral vectors (lentivirus, AAV & CAV-2) used in neurosciences research at the Brain and Spine Intitute

Sobczyk A.; Bonnamy B.; Ripoll C.; Antoine R.; Ravassard P.

首页> 外文期刊>Human gene therapy >iVector, a core facility for bioproduction of viral vectors (lentivirus, AAV & CAV-2) used in neurosciences research at the Brain and Spine Intitute

【24h】

iVector, a core facility for bioproduction of viral vectors (lentivirus, AAV & CAV-2) used in neurosciences research at the Brain and Spine Intitute

机译：viver，一种用于生物生产病毒载体（Lentivirus，Aav＆CAM-2）的核心设施，用于大脑和脊柱的神经科学研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Human gene therapy》 |2018年第12期|共1页
作者
Sobczyk A.; Bonnamy B.; Ripoll C.; Antoine R.; Ravassard P.;
展开▼
作者单位

Inst Cerveau &

Moelle Epiniere Paris France;

Inst Cerveau &

Moelle Epiniere Paris France;

Inst Cerveau &

Moelle Epiniere Paris France;

Inst Cerveau &

Moelle Epiniere Paris France;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. iVector, a core facility for bioproduction of viral vectors (lentivirus, AAV & CAV-2) used in neurosciences research at the Brain and Spine Intitute [J] . Sobczyk A., Bonnamy B., Ripoll C., Human gene therapy . 2018,第12期

机译：viver，一种用于生物生产病毒载体（Lentivirus，Aav＆CAM-2）的核心设施，用于大脑和脊柱的神经科学研究
2. Generation of efficient human blood progenitor-targeted recombinant adeno-associated viral vectors (AAV) by applying an AAV random peptide library on primary human hematopoietic progenitor cells. [J] . Sellner L, Stiefelhagen M, Kleinschmidt JA, Experimental Hematology: Official Publication of the International Society for Experimental Hematology . 2008,第8期

机译：通过在原代人造血祖细胞上应用AAV随机肽库，生成有效的以人血祖细胞为靶标的重组腺相关病毒载体（AAV）。
3. Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model. [J] . Bjorklund A, Kirik D, Rosenblad C, Brain research . 2000,第1a2期

机译：寻求针对帕金森氏病的神经保护基因疗法：使用腺病毒，AAV和慢病毒载体将GDNF的基因转移至大鼠帕金森氏症的黑质纹状体系统。
4. Recombinant AAV Vectors as Natural Nanoparticles Caused Global and Stable Transgene Expression in Mouse Brain by Intravenous Administration [C] . Hongwei Zhang, Bin Yang, Guangping Gao Annual meeting exposition of the Controlled Release Society . 2011

机译：重组AAV载体作为天然纳米粒子通过静脉给药引起小鼠脑中全局和稳定的转基因表达
5. In utero gene therapy with AAV viral vectors in an inherited lysosomal storage disease animal model. [D] . Karolewski, Brian A. 2005

机译：在具有遗传溶酶体贮积病动物模型的AAV病毒载体进行子宫基因治疗中。
6. Application of a haematopoetic progenitor cell-targeted adeno-associated viral (AAV) vector established by selection of an AAV random peptide library on a leukaemia cell line [O] . Marius Stiefelhagen, Leopold Sellner, Jürgen A Kleinschmidt, 2008

机译：通过选择AAV随机肽文库建立的针对造血祖细胞的腺相关病毒（AAV）载体的应用
7. 542. Transduction of Murine, Nonhuman Primate, and Human Hematopoietic Stem Cells (HSCs) by Recombinant AAV Serotype Vectors: Identification of AAV6 as the Most Efficient Serotype for Human HSCs, and Further Augmentation in Transduction Efficiency In Vitro and In Vivo with Point-Mutations of Tyrosine Residues in the Viral Capsid [O] . 2013

机译：542.通过重组AAV血清型载体进行鼠，非人类灵长类动物和人造造血干细胞（HSC）的转导：AAV6作为人HSC的最有效的血清型，进一步在体外转导效率和体内突变的进一步增加病毒衣壳中的酪氨酸残基
8. Neural Responses to Injury: Prevention, Protection, and Repair. Volume 1. Neuroscience Core Research Facilities [R] . Bazan, N. G. 1997

机译：对损伤的神经反应：预防，保护和修复。第1卷。神经科学核心研究设施

iVector, a core facility for bioproduction of viral vectors (lentivirus, AAV & CAV-2) used in neurosciences research at the Brain and Spine Intitute

著录项

相似文献

相关主题

期刊订阅